[Bacampicillin, a new semisynthetic antibiotic for oral administration in the treatment of urinary tract infections (author's transl)].

Abstract

The Authors report the results obtained administering 2.4 g/die of bacampicillin in a group of 30 patients suffering from both primary and secondary infections of the genito-urinary tracts. The antibiotic displayed excellent tolerability and therapeutic effectiveness, determining in almost all the treated cases either the resolution or, at least, significant improvement of the inflammatory course; only two patients, as a matter of fact, showed mild side effects.

• Authors: L Brontesi, G Breda
• Journal: L'Ateneo parmense. Acta bio-medica : organo della Societa di medicina e scienze naturali di Parma (Ateneo Parmense Acta Biomed) Vol. 49 Issue 5-6 Pg. 487-98 ( 1978) ISSN: 1123-7325 [Print] Italy
• Vernacular Title: La bacampicillina, nuova penicillina semisintetica per uso orale, nella terapia delle infezioni urinarie.
• PMID: 383112 (Publication Type: Clinical Trial, English Abstract, Journal Article)

Chemical References

• Ampicillin

Topics

• Adult
• Aged
• Ampicillin (analogs & derivatives, therapeutic use)
• Blood Sedimentation
• Clinical Trials as Topic
• Drug Evaluation
• Drug Tolerance
• Escherichia coli Infections (drug therapy)
• Female
• Humans
• Male
• Middle Aged
• Proteus Infections (drug therapy)
• Pseudomonas Infections (drug therapy)
• Urinary Tract Infections (drug therapy, etiology)